Chris Gerardi is a faculty member of the conference speaking on the panel titled “Tailoring Remedies to the Misappropriation: Equitable Relief, Damages, or Both.”
CRA is a proud sponsor of this event.
For more information on this event, click here.
This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
Chris Gerardi is a faculty member of the conference speaking on the panel titled “Tailoring Remedies to the Misappropriation: Equitable Relief, Damages, or Both.”
CRA is a proud sponsor of this event.
For more information on this event, click here.
We are pleased to present the latest edition of CRA’s IP Literature Watch. This issue contains pieces on antitrust & IP, licensing, litigation, innovation, law...
Branded pharmaceutical manufacturers are required by law to list all patents in the Orange Book that cover an approved drug product. However,...
